Structures by: Low J. N.
Total: 892
(2RS,6SR)-N-diphenylacetyl-2,6-diphenyl-4-piperidone
C31H27NO2
Acta Crystallographica Section C (2006) 62, 6 o324-o327
a=11.2499(2)Å b=11.8622(3)Å c=18.2320(5)Å
α=90.00° β=107.8750(15)° γ=90.00°
2,4-Dinitrophenylhydrazine
C6H6N4O4
Acta Crystallographica Section C (2006) 62, 6 o318-o320
a=4.7917(2)Å b=11.5905(6)Å c=14.0496(5)Å
α=90.00° β=98.372(3)° γ=90.00°
5-Iodoisatin
C8H4INO2
Acta Crystallographica Section C (2006) 62, 6 o321-o323
a=9.3617(6)Å b=11.0930(5)Å c=7.6482(4)Å
α=90.00° β=101.146(2)° γ=90.00°
7-trifluoromethylisatin
C9H4F3NO2
Acta Crystallographica Section C (2006) 62, 6 o321-o323
a=5.1704(2)Å b=15.5609(11)Å c=10.5780(7)Å
α=90.00° β=102.713(4)° γ=90.00°
2-(4-Chlorophenyl)-5,8,8-trimethyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one
C19H18ClN3O
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=8.5280(12)Å b=8.8610(14)Å c=11.7340(16)Å
α=100.992(10)° β=93.118(15)° γ=110.524(9)°
2-(4-Methoxyphenyl)-5,8,8-trimethyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one
C20H21N3O2
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=17.7659(6)Å b=8.5730(2)Å c=11.3982(3)Å
α=90.00° β=101.094(2)° γ=90.00°
2-(4-Chlorophenyl)-8,8-dimethyl-5-phenyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one
C24H20ClN3O
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=7.6778(2)Å b=8.1298(3)Å c=16.6417(5)Å
α=89.080(2)° β=85.123(2)° γ=72.490(2)°
2-(4-Methylphenyl)-8,8-dimethyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one monohydrate
C19H19N3O,H2O
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=5.8190(7)Å b=10.4640(13)Å c=13.847(2)Å
α=78.447(12)° β=79.647(9)° γ=84.882(12)°
N-(2-Methoxy-6-oxopyrimidin-4-yl)formamide
C6H7N3O3
Acta Crystallographica Section C (2006) 62, 5 o256-o258
a=7.0515(7)Å b=9.0031(12)Å c=11.237(2)Å
α=90.00° β=93.690(11)° γ=90.00°
(2RS,3SR,5RS,6SR)-3,5-dimethyl-N-phenylacetyl-2,6-diphenyl-4-piperidinone
C27H27NO2
Acta Crystallographica Section C (2006) 62, 6 o324-o327
a=9.9503(4)Å b=11.8623(6)Å c=18.5654(8)Å
α=77.920(2)° β=84.699(3)° γ=85.731(2)°
3-(3-Oxo-1,3-dihydroisobenzofuran-1-ylidene)pentane-2,4-dione
C13H10O4
Acta Crystallographica Section C (2007) 63, 6 o332-o333
a=8.2779(3)Å b=8.4719(6)Å c=15.1413(12)Å
α=90.0° β=95.534(6)° γ=90.0°
N-(4-Nitrobenzoyl)-N'-phenylhydrazine
C13H11N3O3
Acta Crystallographica Section C (2007) 63, 6 o334-o336
a=4.6982(6)Å b=9.9532(13)Å c=25.719(4)Å
α=90.00° β=90.00° γ=90.00°
2-cyano-4-iodoacetanilide
C9H7IN2O
Acta Crystallographica Section C (2007) 63, 7 o408-o410
a=4.6657(2)Å b=9.4172(4)Å c=11.6841(4)Å
α=109.7520(17)° β=98.598(2)° γ=90.926(2)°
Acetato(<i>N</i>-phenylpyridine-2-carboxamidato-κ^2^N,N)(<i>N</i>- phenylpyridine-2-carboxamideκ^2^N^1^,O)copper(II)
C26H22CuN4O4
Acta Crystallographica Section C (2007) 63, 7 m293-m296
a=7.96040(10)Å b=23.057(3)Å c=13.227(2)Å
α=90.00° β=90.00° γ=90.00°
Rac-2-isopropyl-3-(2-nitrobenzyl)-1,3-thiazolidin-4-one
C13H16N2O3S
Acta Crystallographica Section C (2007) 63, 7 o411-o414
a=11.7604(4)Å b=14.9847(7)Å c=15.1844(8)Å
α=90.00° β=90.00° γ=90.00°
Benzylmethylammonium hydrogen maleate
C8H12N,C4H3O4
Acta Crystallographica Section C (2007) 63, 10 o585-o587
a=13.1084(10)Å b=5.6177(2)Å c=17.6911(13)Å
α=90.0° β=113.566(7)° γ=90.0°
8-<i>tert</i>-Butyl-7-(4-chlorophenyl)-10-phenyl-5,6-dihydro-10<i>H</i>- benzo[<i>h</i>]pyrazolo[3,4-<i>b</i>]quinoline
C30H26ClN3
Acta Crystallographica Section C (2007) 63, 10 o582-o584
a=13.1170(18)Å b=15.948(3)Å c=17.717(2)Å
α=93.750(11)° β=91.803(9)° γ=101.155(13)°
2-amino-4,6-bis[N-methyl-N-(4-methylphenyl)amino]pyrimidine-5-carbaldehyde
C21H23N5O
Acta Crystallographica Section C (2007) 63, 11 o681-o684
a=8.6844(6)Å b=10.7807(19)Å c=10.8903(10)Å
α=69.998(14)° β=88.918(7)° γ=76.822(13)°
6-amino-5-formyl-1,3-dimethyluracil monohydrate
C7H9N3O3,H2O
Acta Crystallographica Section C (2007) 63, 11 o638-o640
a=15.5815(4)Å b=7.4458(4)Å c=16.8575(8)Å
α=90.00° β=116.408(4)° γ=90.00°
2-amino-4-(indolin-1-yl)-6-methoxypyrimidine-5-carbaldehyde
C14H14N4O2
Acta Crystallographica Section C (2007) 63, 11 o681-o684
a=8.2846(4)Å b=11.2710(4)Å c=15.0024(7)Å
α=108.983(4)° β=95.403(4)° γ=101.908(3)°
Tetraaqua(18-crown-6)neodymium(III) hexacyanoferrate(III) dihydrate
C12H32NdO103,C6FeN63,2(H2O)
Acta Crystallographica Section C (2007) 63, 10 m440-m444
a=19.9552(6)Å b=11.5063(2)Å c=13.9706(3)Å
α=90.00° β=113.4189(11)° γ=90.00°
Triaqua(18-crown-6)europium(III) hexacyanoferrate(III) dihydrate
C12H30EuO93,C6FeN63,2(H2O)
Acta Crystallographica Section C (2007) 63, 10 m440-m444
a=10.9125(3)Å b=11.0947(4)Å c=14.0119(3)Å
α=67.8201(18)° β=70.635(2)° γ=65.743(2)°
Triaqua(18-crown-6)gadolinium(III) hexacyanochromate(III) dihydrate
C12H30GdO93,C6CrN63,2(H2O)
Acta Crystallographica Section C (2007) 63, 10 m440-m444
a=11.0563(2)Å b=11.1562(2)Å c=14.2127(3)Å
α=68.3494(11)° β=70.0959(12)° γ=66.0299(12)°
Triaqua(18-crown-6)gadolinium(III) hexacyanocobaltate(III) dihydrate
C12H30GdO93,C6CoN63,2(H2O)
Acta Crystallographica Section C (2007) 63, 10 m440-m444
a=10.8604(2)Å b=11.0724(3)Å c=13.9909(2)Å
α=67.5857(10)° β=70.5870(8)° γ=65.5666(9)°
Triaqua(18-crown-6)samarium(III) hexacyanoferrate(III) dihydrate
C12H30O9Sm3,C6FeN63,2(H2O)
Acta Crystallographica Section C (2007) 63, 10 m440-m444
a=10.9324(2)Å b=11.0996(2)Å c=14.0119(4)Å
α=67.9012(13)° β=70.7291(13)° γ=65.7231(14)°
2-Benzylamino-6-benzyloxypyrimidin-4(3H)-one
C18H17N3O2
Acta Crystallographica Section C (2003) 59, 7 o400-o402
a=10.7611(4)Å b=8.0306(3)Å c=34.9826(17)Å
α=90° β=98.5740(15)° γ=90°
4-Amino-1-benzyl-2-(methylsulfanyl)pyrimidin-6(1H)-one, polymorph with Z' = 1
C12H13N3OS
Acta Crystallographica Section C (2003) 59, 8 o454-o460
a=9.7139(2)Å b=9.5846(2)Å c=12.6431(2)Å
α=90.00° β=103.4465(13)° γ=90.00°
4-Amino-6-benzyloxy-2-(methylsulfanyl)pyrimidine
C12H13N3OS
Acta Crystallographica Section C (2003) 59, 8 o454-o460
a=15.747(2)Å b=5.1044(7)Å c=15.501(3)Å
α=90.00° β=105.286(5)° γ=90.00°
5,7-dimethoxyimidazo[1,2-c]pyrimidine
C8H9N3O2
Acta Crystallographica Section C (2003) 59, 7 o363-o366
a=3.8798(3)Å b=8.9183(6)Å c=12.6224(11)Å
α=69.426(3)° β=83.093(4)° γ=79.189(4)°
7-methoxy-1-methylimidazo[1,2-a]pyrimidin-5(1H)-one
C8H9N3O2
Acta Crystallographica Section C (2003) 59, 7 o363-o366
a=8.5917(6)Å b=6.7484(5)Å c=14.3054(14)Å
α=90.00° β=91.648(3)° γ=90.00°
Potassium N-(6-amino-3,4-dihydro-3-methyl-5-nitroso- 4-oxopyrimidin-2-yl)-(S)-aspartate N-(6-amino-3,4-dihydro-3-methyl- 5-nitroso-4-oxopyrimidin-2-yl)-(S)-aspartic acid 4.88(hydrate)
K1,C9H10N5O61,C9H11N5O6,4.88H2O
Acta Crystallographica Section C (2003) 59, 8 m315-m318
a=7.49860(10)Å b=13.0997(2)Å c=29.5866(6)Å
α=90.00° β=90.00° γ=90.00°
Bis[6-amino-3-methyl-5-nitrosopyrimidine-2,4(1H,3H)-dionato]diaquazinc(II) dihydrate
C10H14N8O8Zn,2H2O
Acta Crystallographica Section C (2003) 59, 7 m291-m293
a=11.3625(2)Å b=9.5848(2)Å c=8.0433(2)Å
α=102.2410(8)° β=94.2412(11)° γ=97.7735(11)°
4-Amino-1-benzyl-2-(methylsulfanyl)pyrimidin-6(1H)-one, polymorph with Z' = 2 'C12 H13 N3 O S'
C24H25.95N6.05O2.05S2
Acta Crystallographica Section C (2003) 59, 8 o454-o460
a=11.4629(2)Å b=10.2603(2)Å c=20.9303(4)Å
α=90.00° β=107.0920(14)° γ=90.00°
Rac-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-phenyl-thiazolidin-4-one
C19H18N4OS
Acta Crystallographica Section C (2004) 60, 7 o486-o488
a=10.7937(4)Å b=11.3989(2)Å c=14.2448(5)Å
α=79.993(2)° β=83.3490(14)° γ=89.852(2)°
S-Ethyl N-benzoyldithiocarbamate
C10H11NOS2
Acta Crystallographica Section C (2004) 60, 7 o483-o485
a=21.8190(5)Å b=8.4596(2)Å c=23.1792(5)Å
α=90.00° β=94.5140(14)° γ=90.00°
N-(4-Fluorophenyl)-4-nitrophthalimide
C14H7FN2O4
Acta Crystallographica Section C (2004) 60, 7 o511-o513
a=3.7492(13)Å b=6.9376(14)Å c=23.099(8)Å
α=90.00° β=90.118(11)° γ=90.00°
9-(4-Chlorophenyl)-7-methyl-5,6-dihydrobenzo[h]pyrazolo[3,2-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=9.2382(8)Å b=10.3054(8)Å c=10.3184(9)Å
α=62.720(4)° β=83.098(4)° γ=70.531(5)°
1,3,5-triphenylperhydro-1,3,5-triazine-2,4,6-trione, orthorhombic polymorph
C21H15N3O3
Acta Crystallographica Section C (2004) 60, 9 o682-o685
a=23.3764(8)Å b=37.1079(12)Å c=7.7091(2)Å
α=90.00° β=90.00° γ=90.00°
1,3,5-triphenylperhydro-1,3,5-triazine-2,4,6-trione, monoclinic polymorph
C21H15N3O3
Acta Crystallographica Section C (2004) 60, 9 o682-o685
a=15.6526(3)Å b=13.6819(3)Å c=9.6454(2)Å
α=90.00° β=126.035(2)° γ=90.00°
2-Nitrobenzaldehyde hydrazone
C7H7N3O2
Acta Crystallographica Section C (2004) 60, 9 o686-o689
a=3.6675(2)Å b=13.9380(10)Å c=28.796(2)Å
α=90.00° β=90.00° γ=90.00°
{2-[(benzoylmethylene)diphenyl-λ^5^-phosphino]ethyl}diphenylphosphine monohydrate
C34H30O1.68P2,H2O
Acta Crystallographica Section C (2004) 60, 7 o475-o478
a=9.1392(4)Å b=11.8931(3)Å c=13.6025(5)Å
α=105.725(2)° β=92.472(2)° γ=101.934(2)°
3-Nitrobenzaldehyde hydrazone
C7H7N3O2
Acta Crystallographica Section C (2004) 60, 9 o686-o689
a=3.7231(2)Å b=10.2200(7)Å c=19.4119(12)Å
α=90.00° β=90.00° γ=90.00°
<i>m</i>-quinquephenyl
C30H22
Acta Crystallographica Section C (2012) 68, 12 o492-o497
a=13.5740(7)Å b=7.1809(4)Å c=42.833(2)Å
α=90.00° β=99.274(4)° γ=90.00°
3-bromo-5-nitrosalicylaldehyde phenylhydrazone
C13H10BrN3O3
Acta Crystallographica Section C (2013) 69, 2 150-155
a=8.517(4)Å b=21.699(9)Å c=14.301(6)Å
α=90.00° β=90.310(9)° γ=90.00°
4-Allyloxy-7-chloroquinoline
C12H10ClNO
Acta Crystallographica Section C (2013) 69, 2 191-194
a=3.9370(9)Å b=11.977(3)Å c=21.482(6)Å
α=90.00° β=90.00° γ=90.00°
7-Chloro-4-methoxyquinoline
C10H8ClNO
Acta Crystallographica Section C (2013) 69, 2 191-194
a=3.8120(4)Å b=10.9801(11)Å c=20.348(2)Å
α=90.00° β=93.591(7)° γ=90.00°
7-Chloro-4-ethoxyquinoline
C11H10ClNO
Acta Crystallographica Section C (2013) 69, 2 191-194
a=3.932(10)Å b=11.98(3)Å c=20.86(6)Å
α=90.00° β=90.56(6)° γ=90.00°
5-Bromo-3-nitrosalicylaldehyde phenylhydrazone
C13H10BrN3O3
Acta Crystallographica Section C (2013) 69, 2 150-155
a=7.9022(11)Å b=11.7662(17)Å c=14.917(2)Å
α=68.971(5)° β=83.143(6)° γ=88.375(6)°
<i>N</i>-Cyclohexyl-2-(methylsulfanyl)nicotinamide
C13H18N2OS
Acta Crystallographica Section C (2013) 69, 3 293-298
a=11.5273(9)Å b=13.4634(10)Å c=8.3956(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(2-Hydroxyethyl)-2-(methylsulfanyl)nicotinamide dihydrate
C9H12N2O2S,2(H2O)
Acta Crystallographica Section C (2013) 69, 3 293-298
a=7.194(2)Å b=7.285(3)Å c=22.388(8)Å
α=90.00° β=90.341(5)° γ=90.00°
<i>N</i>-Methyl-<i>N</i>'-(2-nitrobenzylidene)pyrazine-2-carbohydrazide
C13H11N5O3
Acta Crystallographica Section C (2013) 69, 5 549-555
a=3.7974(2)Å b=33.3126(17)Å c=10.0959(5)Å
α=90.00° β=99.027(2)° γ=90.00°
(E)-2-(2-(hydrazinyl)quinoxaline
C15H12N4
Acta Crystallographica Section C (2013) 69, 8 920-926
a=6.483(7)Å b=21.36(3)Å c=17.56(2)Å
α=90.00° β=90.96(3)° γ=90.00°
(<i>E</i>)-2-(2-(2-chlorobenzylidene)hydrazinyl)quinoxaline
C15H11ClN4
Acta Crystallographica Section C (2013) 69, 8 920-926
a=6.6870(7)Å b=7.2591(8)Å c=13.8150(16)Å
α=77.957(6)° β=77.357(6)° γ=75.560(5)°
(<i>E</i>)-2-(2-(3-chlorobenzylidene)hydrazinyl)quinoxaline
C15H11ClN4
Acta Crystallographica Section C (2013) 69, 8 920-926
a=32.14(5)Å b=6.882(9)Å c=12.450(18)Å
α=90.00° β=108.43(3)° γ=90.00°
(<i>E</i>)-2-(2-(4-chlorobenzylidene)hydrazinyl)quinoxaline
C15H11ClN4
Acta Crystallographica Section C (2013) 69, 8 920-926
a=11.6658(6)Å b=10.0515(5)Å c=11.7575(8)Å
α=90.00° β=104.818(7)° γ=90.00°
(<i>E</i>)-2-(2-(2-bromobenzylidene)hydrazinyl)quinoxaline
C15H11BrN4
Acta Crystallographica Section C (2013) 69, 8 920-926
a=6.9712(10)Å b=12.6370(17)Å c=30.182(4)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-2-(2-(3-bromobenzylidene)hydrazinyl)quinoxaline
C15H11BrN4
Acta Crystallographica Section C (2013) 69, 8 920-926
a=32.781(17)Å b=6.875(3)Å c=12.466(6)Å
α=90.00° β=109.096(11)° γ=90.00°
(<i>E</i>)-2-(2-(4-bromobenzylidene)hydrazinyl)quinoxaline
C15H11BrN4
Acta Crystallographica Section C (2013) 69, 8 920-926
a=12.002(5)Å b=9.170(3)Å c=12.617(5)Å
α=90.00° β=100.004(6)° γ=90.00°
Tetra(neophyl)tin
C40H52Sn
Acta Crystallographica Section C (2000) 56, 1 e3-e3
a=13.9224(4)Å b=9.9590(2)Å c=25.6952(6)Å
α=90.00° β=104.5178(14)° γ=90.00°
Hexaaquomagnesium(II) di[N-(6-amino-3,4-dihydro-3-methyl-5-nitroso-4-oxo- pyrimidin-2-yl)glycinate] dihydrate
2(C7H8N5O4),H12MgO6,2(H2O)
Acta Crystallographica Section C (2000) 56, 1 e4-e5
a=7.3152(3)Å b=7.5917(4)Å c=12.3024(6)Å
α=86.661(3)° β=73.172(3)° γ=81.79(3)°
2-Amino-4-methoxy-6-phenyl-11<i>H</i>-pyrimido[4,5-<i>b</i>][1,4]benzodiazepine
C18H15N5O
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=7.022(6)Å b=12.855(9)Å c=16.199(8)Å
α=90.00° β=93.851(5)° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-methoxybenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione
C31H37N3O3
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=9.5971(8)Å b=11.2549(16)Å c=12.1452(14)Å
α=86.979(11)° β=85.487(10)° γ=87.216(7)°
3-<i>tert</i>-butyl-7-(2,3-dimethoxybenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione
C32H39N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=12.4683(15)Å b=10.2892(12)Å c=21.7635(16)Å
α=90.00° β=90.843(10)° γ=90.00°
3-<i>tert</i>-butyl-1-phenyl-7-(4-trifluoromethylbenzyl)-4,5,6,7-tetrahydro- 1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane-2',6'-dione
C29H30F3N3O2
Acta Crystallographica Section C (2008) 64, 12 o671-o674
a=11.9298(18)Å b=10.5678(10)Å c=19.614(2)Å
α=90.00° β=96.627(10)° γ=90.00°
3-<i>tert</i>-butyl-7-(4-methoxybenzyl)-1-phenyl-4,5,6,7-tetrahydro- 1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane-2',6'-dione
C29H33N3O3
Acta Crystallographica Section C (2008) 64, 12 o671-o674
a=9.1904(10)Å b=11.9402(14)Å c=22.2888(16)Å
α=90.00° β=97.287(9)° γ=90.00°
(1RS,2SR,3RS,5SR)-2-Benzoyl-4,4-dicyano-1,3,5-triphenylcyclohexanol
C33H26N2O2
Acta Crystallographica Section C (2008) 64, 10 o578-o582
a=10.9251(18)Å b=11.777(3)Å c=11.9438(12)Å
α=90.417(13)° β=112.616(9)° γ=112.750(14)°
3-<i>tert</i>-Butyl-4',4'-dimethyl-7-(4-methylbenzyl)-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C31H37N3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.281(5)Å b=10.6438(15)Å c=21.567(3)Å
α=90.00° β=122.082(12)° γ=90.00°
3-<i>tert</i>-Butyl-4',4'-dimethyl-1-phenyl-7-[4-(trifluoromethyl)benzyl]- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione ethanol hemisolvate
C31H34F3N3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=10.3270(12)Å b=11.9970(14)Å c=12.427(3)Å
α=75.016(13)° β=70.059(11)° γ=84.481(9)°
2-Amino-4-methoxy-6-(2-fluorophenyl)-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,4]benzodiazepine
C18H14FN5O
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=6.9115(10)Å b=12.8801(14)Å c=16.560(2)Å
α=90.00° β=95.110(10)° γ=90.00°
2-Amino-4-methoxy-6-(3-nitrophenyl)-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,4]benzodiazepine
C18H14N6O3
Acta Crystallographica Section C (2008) 64, 12 o643-o648
a=7.047(4)Å b=13.502(7)Å c=16.418(5)Å
α=90.00° β=91.22(5)° γ=90.00°
3-<i>tert</i>-butyl-4',4'-dimethyl-1-phenyl-7-(3,4,5-trimethoxybenzyl)- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione ethanol 0.67-solvate
C33H41N3O5,0.67(C2H6O)
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=13.5770(17)Å b=17.476(3)Å c=26.670(3)Å
α=90.00° β=90.00° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-chlorobenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C30H34ClN3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.419(4)Å b=10.5860(13)Å c=21.580(3)Å
α=90.00° β=122.625(11)° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-bromobenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione ethanol hemisolvate
C30H34BrN3O2,0.5C2H6O
Acta Crystallographica Section C (2008) 64, 12 o637-o642
a=27.4453(7)Å b=10.5519(8)Å c=21.715(2)Å
α=90.00° β=122.484(7)° γ=90.00°
1-(6-amino-1,3-benzodioxol-5-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
C19H19NO6
Acta Crystallographica Section C (2002) 58, 1 o42-o45
a=23.5477(4)Å b=4.96050(10)Å c=14.2556(8)Å
α=90° β=100.7020(10)° γ=90°
1-(6-amino-1,3-benzodioxol-5-yl)-3-[4-(N,N-dimethylamino)phenyl]prop-2-en-1-one
C18H18N2O3
Acta Crystallographica Section C (2002) 58, 1 o42-o45
a=9.5849(2)Å b=12.3218(4)Å c=13.3304(4)Å
α=83.4617(14)° β=80.2411(17)° γ=85.7271(16)°
Phthalimide [1H-Isoindole-1,3(2H)-dione]
C8H5NO2
Acta Crystallographica Section C (2002) 58, 1 o9-o10
a=3.7303(2)Å b=7.6638(4)Å c=22.6435(13)Å
α=90.00° β=90.369(2)° γ=90.00°
5-(3-(4-methylphenyl)-2-propenylidene]-2,2-dimethyl-[1,3] dioxane-4,6-dione
C16H16O4
Acta Crystallographica Section C (2002) 58, 1 o39-o41
a=11.2891(3)Å b=11.4128(4)Å c=13.4504(5)Å
α=91.217(2)° β=114.640(3)° γ=113.7590(15)°
Catena-Poly[penta-aquabis{N-(6-amino-3,4-dihydro-3-methyl-5-nitroso- 4-oxopyrimidin-2-yl)glycinate}strontium monohydrate]
C14H26N10O13Sr,H2O
Acta Crystallographica Section C (2002) 58, 1 m61-m64
a=25.0078(8)Å b=6.74160(10)Å c=14.3677(4)Å
α=90.00° β=92.4950(10)° γ=90.00°
5-(3-(4-chlorophenyl)-2-propenylidene]-2,2-dimethyl-[1,3] dioxane-4,6-dione
C15H13ClO4
Acta Crystallographica Section C (2002) 58, 1 o39-o41
a=7.2648(2)Å b=7.4705(3)Å c=13.5855(6)Å
α=90.1799(13)° β=99.8452(14)° γ=109.576(3)°
4-(4-Chlorophenyl)-3,7,7-trimethyl-1-[2-(4-nitrobenzoyl)ethyl]-4,7,8,9- tetrahydro-1H-pyrazolo[3,4-b]quinolin-5(6H)-one-ethanol (1/1)
C28H27ClN4O4,C2H6O
Acta Crystallographica Section C (2001) 57, 11 1356-1358
a=23.6298(6)Å b=9.6215(3)Å c=14.2657(4)Å
α=90° β=120.2930(16)° γ=90°
2-Methyl-4-nitroaniline
C7H8N2O2
Acta Crystallographica Section C (2001) 57, 3 315-316
a=7.6113(5)Å b=11.6304(7)Å c=8.2286(5)Å
α=90.00° β=94.050(2)° γ=90.00°
4-Oxo-<i>N</i>-phenyl-4<i>H</i>-chromene-2-carboxamide
C16H11NO3
Acta Crystallographica Section C (2013) 69, 12 1527-1533
a=8.6591(12)Å b=4.9980(7)Å c=28.346(4)Å
α=90.00° β=98.042(3)° γ=90.00°
7-Methoxy-4-oxo-<i>N</i>-<i>p</i>-tolyl-4<i>H</i>-chromene-2-carboxamide hemihydrate
C18H15NO4,0.5(H2O)
Acta Crystallographica Section C (2013) 69, 12 1527-1533
a=12.989(12)Å b=8.301(7)Å c=29.11(2)Å
α=90.00° β=94.29(2)° γ=90.00°
7-Methoxy-4-oxo-<i>N</i>-<i>p</i>-tolyl-4<i>H</i>-chromene-2-carboxamide
C18H15NO4
Acta Crystallographica Section C (2013) 69, 12 1527-1533
a=5.7544(4)Å b=8.0892(5)Å c=15.6269(14)Å
α=101.926(7)° β=95.366(9)° γ=92.579(9)°
(Z)-5-(2-fluorobenzylidene)-2-thioxothaolidin-2-one
C10H6FNOS2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=11.1848(4)Å b=7.7651(4)Å c=12.3611(5)Å
α=90.00° β=107.417(3)° γ=90.00°
(Z)-5-(4-fluorobenzylidene)-2-thioxothaolidin-2-one
C10H6FNOS2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=4.9173(2)Å b=19.8906(10)Å c=10.4976(6)Å
α=90.00° β=92.929(3)° γ=90.00°
4-Iodo-N,N-bis(2-nitrophenylsulfonyl)aniline
C18H12IN3O8S2
Acta Crystallographica Section C (2006) 62, 7 o423-o425
a=12.1680(2)Å b=18.6695(4)Å c=9.0443(2)Å
α=90.00° β=100.030(2)° γ=90.00°
N-(2-Hydroxy-3-iodo-5-nitrobenzylidene)-3-nitroaniline
C13H8IN3O5
Acta Crystallographica Section C (2006) 62, 7 o441-o443
a=9.2957(4)Å b=27.5905(13)Å c=11.0084(5)Å
α=90.00° β=93.830(2)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-diphenylpentane-1,5-dione
C27H23ClN2O2
Acta Crystallographica Section C (2006) 62, 8 o518-o520
a=15.2964(3)Å b=17.4366(2)Å c=16.8320(3)Å
α=90.00° β=90.00° γ=90.00°
2,4-Dimethylbenzaldehyde isonicotinoylhydrazone trihydrate
C15H15N3O,3H2O
Acta Crystallographica Section C (2006) 62, 7 o444-o446
a=8.6765(7)Å b=9.0833(6)Å c=11.2901(9)Å
α=73.870(5)° β=82.182(4)° γ=65.147(3)°
N-(6-amino-3-methyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)- N-[β-D-glucopyranosyl]acetamide
C13H20N4O8,2H2O1
Acta Crystallographica Section C (2000) 56, 9 e420-e420
a=7.09110(10)Å b=12.2566(2)Å c=20.5272(4)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(5-amino-3-methyl-1H-pyrazol-1-yl)benzoate
C13H15N3O2
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=7.2228(4)Å b=8.4433(3)Å c=10.5938(5)Å
α=98.234(3)° β=107.609(2)° γ=97.907(3)°
Methyl 4-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)benzoate
C15H19N3O2
Acta Crystallographica Section C (2007) 63, 1 o21-o25
a=6.1272(2)Å b=11.6374(3)Å c=20.3182(7)Å
α=90.00° β=98.629(2)° γ=90.00°
2,3-Dimethoxybenzaldehyde isonicotinoylhydrazone chloroform monosolvate
C15H15N3O3,CHCl3
Acta Crystallographica Section C (2007) 63, 1 o68-o72
a=12.7400(4)Å b=10.8595(3)Å c=13.9187(4)Å
α=90.00° β=110.7280(10)° γ=90.00°
3,4,5-trimethoxybenzaldehyde isonicotinoylhydrazone dihydrate
C16H17N3O4,2H2O
Acta Crystallographica Section C (2007) 63, 1 o68-o72
a=8.9930(5)Å b=16.2713(10)Å c=11.6311(6)Å
α=90.00° β=90.354(3)° γ=90.00°
3-tert-butyl-5-[(4-methoxybenzyl)amino]-1-phenyl-1H-pyrazole
C21H25N3O
Acta Crystallographica Section C (2007) 63, 1 o29-o32
a=10.9665(14)Å b=10.9665(14)Å c=30.796(6)Å
α=90.00° β=90.00° γ=90.00°
5-[(benzotriazol-1-ylmethyl)(4-methoxybenzyl)amino]-3-tert-butyl-1- phenyl-1H-pyrazole
C28H30N6O
Acta Crystallographica Section C (2007) 63, 1 o29-o32
a=12.5184(2)Å b=18.5142(5)Å c=21.7580(5)Å
α=90.00° β=96.0730(15)° γ=90.00°
7-Amino-2-tert-butyl-5-methylpyrazolo[1,5-a]pyrimidine
C11H16N4
Acta Crystallographica Section C (2007) 63, 1 o26-o28
a=10.8271(2)Å b=10.8271(2)Å c=19.9208(3)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 5-amino-1-(4-cyanophenyl)-1H-imidazole-4-carboxylate
C13H12N4O2
Acta Crystallographica Section C (2007) 63, 1 o33-o37
a=6.3212(5)Å b=9.4121(11)Å c=10.2496(12)Å
α=90.311(5)° β=94.183(7)° γ=92.946(7)°
Ethyl 5-amino-1-(2,6-difluorophenyl)-1H-imidazole-4-carboxylate
C12H11F2N3O2
Acta Crystallographica Section C (2007) 63, 1 o33-o37
a=7.9045(4)Å b=12.9950(7)Å c=11.7737(5)Å
α=90.00° β=98.810(4)° γ=90.00°